User:Bs20dp/Muramyl dipeptide/Bibliography

Ogawa C, Liu YJ, Kobayashi KS. Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011 Sep;7(3):180-197. doi: 10.2174/157340711796817913. PMID: 22180736; PMCID: PMC3241611.^[1]

Naohiro Inohara, Yasunori Ogura, Ana Fontalba, Olga Gutierrez, Fernando Pons, Javier Crespo, Koichi Fukase, Seiichi Inamura, Shoichi Kusumoto, Masahito Hashimoto, Simon J. Foster, Anthony P. Moran, Jose L. Fernandez-Luna, Gabriel Nuñez. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2: IMPLICATIONS FOR CROHN′S DISEASE.* Journal of Biological Chemistry, Volume 278, Issue 8, 2003, Pages 5509-5512, ISSN 0021-9258, https://doi.org/10.1074/jbc.C200673200.^[2]

Watanabe, Tomohiro; Asano, Naoki; Murray, Peter J.; Ozato, Keiko; Tailor, Prafullakumar; Fuss, Ivan J.; Kitani, Atsushi; Strober, Warren (2008-01-10). "Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis". Journal of Clinical Investigation. doi:10.1172/JCI33145. ISSN 0021-9738.^[3]

Li X, Yu J, Xu S, Wang N, Yang H, Yan Z, Cheng G, Liu G. Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer. Glycoconj J. 2008;25(5):415–25. [PubMed] [Google Scholar]^[4]

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.

Bibliography

As you gather the sources for your Wikipedia contribution, think about the following:

Is the source from a reliable publication?
- Reliable publications include established newspapers, academic journals and books, textbooks, and other published sources with reputations for accuracy and fact-checking.
- Unreliable sources include blog posts and other self-published works, press releases, and social media posts.
Is the source verifiable?
- In order for a source to be considered verifiable, other editors should be able to consult the source.
Is the source independent of the subject?
- Is the source connected in any way to the subject? This is especially important when writing biographies or about organizations.
- For example, if you were writing a biography, sources like the person's webpage or personal blog would not be considered independent.
Is the source primary or secondary?
- Primary sources include first-hand accounts, autobiographies, and other original content.
- Wikipedia allows limited use of primary sources, but typically only for straightforward, descriptive statements of facts, and only if they are published and verifiable without requiring specialized knowledge.
- Secondary sources should be the main basis for a biography on Wikipedia.
If you're working on a topic related to medicine or psychology, ensure that your sources follow these special guidelines.
If you're creating a new article, consider the following:
- Ensure that your topic meets Wikipedia's notability guidelines.
- In order for a topic to meet the notability requirement, you must be able to identify 2-3 sources that are reliable, verifiable, and independent of the subject you're writing about.
- Finding sufficient sources to establish notability can be especially hard when writing about people or organizations.
- Sources that are not independent of the subject might be useful additions, but don't count towards the notability requirement.
- Wikipedia has developed special guidelines for writing about living persons. Please follow these carefully.
- Wikipedia has a series of guidelines for writing about different categories of people, such as academics and artists. If you're trying to create a new entry about a living person, please look at these carefully.

If you're not sure whether a source is reliable, ask a librarian! If you have questions about Wikipedia's sourcing rules, you can use the Get Help button below to contact your Wikipedia Expert.

Get Help

Bibliography

Ogawa C, Liu YJ, Kobayashi KS. Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. Curr Bioact Compd. 2011 Sep;7(3):180-197. doi: 10.2174/157340711796817913. PMID: 22180736; PMCID: PMC3241611.^[1]

Naohiro Inohara, Yasunori Ogura, Ana Fontalba, Olga Gutierrez, Fernando Pons, Javier Crespo, Koichi Fukase, Seiichi Inamura, Shoichi Kusumoto, Masahito Hashimoto, Simon J. Foster, Anthony P. Moran, Jose L. Fernandez-Luna, Gabriel Nuñez. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2: IMPLICATIONS FOR CROHN′S DISEASE.* Journal of Biological Chemistry, Volume 278, Issue 8, 2003, Pages 5509-5512, ISSN 0021-9258, https://doi.org/10.1074/jbc.C200673200.^[2]

Watanabe, Tomohiro; Asano, Naoki; Murray, Peter J.; Ozato, Keiko; Tailor, Prafullakumar; Fuss, Ivan J.; Kitani, Atsushi; Strober, Warren (2008-01-10). "Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis". Journal of Clinical Investigation. doi:10.1172/JCI33145. ISSN 0021-9738.^[3]

Li X, Yu J, Xu S, Wang N, Yang H, Yan Z, Cheng G, Liu G. Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer. Glycoconj J. 2008;25(5):415–25. [PubMed] [Google Scholar]^[4]

References

^ ^a ^b Ogawa, Chikako; Liu, Yuen-Joyce; Kobayashi, Koichi S. "Muramyl Dipeptide and its Derivatives: Peptide Adjuvant in Immunological Disorders and Cancer Therapy". Current Bioactive Compounds. 7 (3): 180–197. doi:10.2174/157340711796817913. PMC 3241611. PMID 22180736.{{cite journal}}: CS1 maint: PMC format (link)
^ ^a ^b Inohara, Naohiro; Ogura, Yasunori; Fontalba, Ana; Gutierrez, Olga; Pons, Fernando; Crespo, Javier; Fukase, Koichi; Inamura, Seiichi; Kusumoto, Shoichi; Hashimoto, Masahito; Foster, Simon J.; Moran, Anthony P.; Fernandez-Luna, Jose L.; Nuñez, Gabriel (2003-02). "Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2". Journal of Biological Chemistry. 278 (8): 5509–5512. doi:10.1074/jbc.C200673200. {{cite journal}}: Check date values in: |date= (help)CS1 maint: unflagged free DOI (link)
^ ^a ^b Watanabe, Tomohiro; Asano, Naoki; Murray, Peter J.; Ozato, Keiko; Tailor, Prafullakumar; Fuss, Ivan J.; Kitani, Atsushi; Strober, Warren (2008-01-10). "Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis". Journal of Clinical Investigation. doi:10.1172/JCI33145. ISSN 0021-9738.
^ ^a ^b Li, Xuqin; Yu, Junli; Xu, Song; Wang, Nan; Yang, Hongzhen; Yan, Zheng; Cheng, Guifang; Liu, Gang (2008-07). "Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer". Glycoconjugate Journal. 25 (5): 415–425. doi:10.1007/s10719-007-9095-3. ISSN 0282-0080. {{cite journal}}: Check date values in: |date= (help)

Outline of proposed changes

Click on the edit button to draft your outline.

Now that you have compiled a bibliography, it's time to plan out how you'll improve your assigned article.

In this section, write up a concise outline of how the sources you've identified will add relevant information to your chosen article. Be sure to discuss what content gap your additions tackle and how these additions will improve the article's quality.

Consider other changes you'll make to the article, including possible deletions of irrelevant, outdated, or incorrect information, restructuring of the article to improve its readability or any other change you plan on making. This is your chance to really think about how your proposed additions will improve your chosen article and to vet your sources even further.

Note: This is not a draft. This is an outline/plan where you can think about how the sources you've identified will fill in a content gap.

Get Help

[:0-1] Ogawa, Chikako; Liu, Yuen-Joyce; Kobayashi, Koichi S. "Muramyl Dipeptide and its Derivatives: Peptide Adjuvant in Immunological Disorders and Cancer Therapy". Current Bioactive Compounds. 7 (3): 180–197. doi:10.2174/157340711796817913. PMC 3241611. PMID 22180736.{{cite journal}}: CS1 maint: PMC format (link)

[:1-2] Inohara, Naohiro; Ogura, Yasunori; Fontalba, Ana; Gutierrez, Olga; Pons, Fernando; Crespo, Javier; Fukase, Koichi; Inamura, Seiichi; Kusumoto, Shoichi; Hashimoto, Masahito; Foster, Simon J.; Moran, Anthony P.; Fernandez-Luna, Jose L.; Nuñez, Gabriel (2003-02). "Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2". Journal of Biological Chemistry. 278 (8): 5509–5512. doi:10.1074/jbc.C200673200. {{cite journal}}: Check date values in: |date= (help)CS1 maint: unflagged free DOI (link)

[:2-3] Watanabe, Tomohiro; Asano, Naoki; Murray, Peter J.; Ozato, Keiko; Tailor, Prafullakumar; Fuss, Ivan J.; Kitani, Atsushi; Strober, Warren (2008-01-10). "Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis". Journal of Clinical Investigation. doi:10.1172/JCI33145. ISSN 0021-9738.

[:3-4] Li, Xuqin; Yu, Junli; Xu, Song; Wang, Nan; Yang, Hongzhen; Yan, Zheng; Cheng, Guifang; Liu, Gang (2008-07). "Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer". Glycoconjugate Journal. 25 (5): 415–425. doi:10.1007/s10719-007-9095-3. ISSN 0282-0080. {{cite journal}}: Check date values in: |date= (help)

[1]

[2]

[3]

[4]